Form 4: IGM Biosciences Director Receives Stock as Quarterly Retainer

Director Jakob Haldor Topsoe receives 1,734 shares of IGM Biosciences common stock as a quarterly retainer, while Topsoe Holding A/S indirectly holds a significant stake.

Summary

• On March 29, 2024, Jakob Haldor Topsoe, a director of IGM Biosciences, received 1,734 shares of common stock as a quarterly retainer.
• The shares were awarded under the Issuer's Outside Director Compensation Policy.
• Following the transaction, Mr. Topsoe directly owns 84,854 shares of IGM Biosciences common stock.
• Topsoe Holding A/S indirectly holds 10,400,564 shares.
• Jakob Haldor Topsoe, along with other board members of Topsoe Holding A/S, may be deemed to share voting and investment power over these shares, but disclaims beneficial ownership except to the extent of his or her pecuniary interest.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally neutral. The large indirect holding by Topsoe Holding A/S suggests confidence in the company.

Positives

• The receipt of stock as a retainer aligns the director's interests with those of the shareholders.
• The director's compensation policy is transparent.

Industry Context

Director compensation in the biotech industry often includes stock options and restricted stock units to align management's interests with those of shareholders. This Form 4 filing reflects a common practice of compensating outside directors with company stock.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates